Lisa Graver, CEO
Lisa Graver serves as the CEO for Alvogen and its affiliate Almatica. She brings over 20 years of distinguished experience in the pharmaceutical industry to her role. Her profound knowledge in patent law and regulatory strategy has been integral to Alvogen’s success. Under Lisa’s leadership, Almatica is actively pursuing the expansion of its US product portfolio through development and acquisition of products.
Leadership Team
Almatica’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market.
Tunie Zaku
CFO
Rama Yarasani
CSO
Emily Smith
VP - Human Resources